Effect of the Omentectomy on the Hyperglycemia and the Resistance to the Insulin in Patients With Morbid Obesity
NCT00454597 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2008-06-04
Summary
To determine if the omentectomy diminishes hyperglycemia and improves the resistance to the insulin in patients with morbid obesity and propensity to develop to Diabetes Mellitus type 2.
Conditions
- Obesity
- Diabetes Mellitus Type 2
Interventions
- PROCEDURE
-
omentectomy
surgery omentectomy
Sponsors & Collaborators
-
Universidad de Guanajuato
lead OTHER
Principal Investigators
-
Arturo MD Reyes Hernandez, Surgery · Universidad de Guanajuato, Facultad de Medicina de León, Hospital General Regional de León
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2007-03-31
- Completion
- 2007-12-31
Countries
- Mexico
Study Locations
More Related Trials
-
The Role of Pulsatile Insulin Secretion (A Study Investigating the Effects of Partial Pacreatectomy on Glucose Metabolism)
NCT00841867 ·Status: COMPLETED
-
Neuroendocrine Brake for Type 2 Diabetes Mellitus
NCT00450710 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of RYGB on Alpha- and Beta Cell Function and Sensitivity to Incretins in Patients With Type 2 Diabetes
NCT04782999 ·Status: COMPLETED ·Phase: NA
-
Effects of GLP-1 Agonists on Gastric Volume
NCT05854979 ·Status: COMPLETED
-
Antrum Size, Glucagon-like Peptide 1 Levels and Glycemic Control After Sleeve Gastrectomy in Morbid Obese Diabetic Adolescents
NCT04388059 ·Status: COMPLETED
-
Human Versus Analogue Insulin in Patients After Pancreatectomy.
NCT04690309 ·Status: UNKNOWN ·Phase: PHASE4
-
The Influence of Cholecystectomy on Secretion of Incretin Hormones
NCT03305783 ·Status: COMPLETED
-
Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes
NCT02497313 ·Status: COMPLETED ·Phase: NA
-
Role of the Liver in Glucose Homeostasis Using Metabolic Imaging
NCT04352738 ·Status: COMPLETED
-
Endogenous Glucoseproduction in Patients With Type 2 Diabetes Mellitus During Oral Glucose and iv. Glucose Infusion
NCT02010827 ·Status: COMPLETED
-
Prevalence of Metabolic Liver Diseases in Patients With Type 1 Diabetes Mellitus
NCT05054712 ·Status: UNKNOWN
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA
-
Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic Steatosis
NCT04270656 ·Status: COMPLETED ·Phase: NA
-
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
NCT05499702 ·Status: RECRUITING ·Phase: PHASE2
-
The Importance of GLP-1 in Post RYGB Improvement in Glycaemic Control Type 2 Diabetic Subjects
NCT01579981 ·Status: COMPLETED ·Phase: NA
-
Effect of Novel Glucagon Receptor Antagonist REMD-477 on Glucose and Adipocyte Metabolism in T2DM
NCT05093517 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
NCT05414409 ·Status: RECRUITING ·Phase: PHASE2
-
The Effect of Roux-en-Y Gastric Bypass on Insulin Sensitivity in Type 2 Diabetes
NCT01202526 ·Status: COMPLETED
-
The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Mellitus
NCT00568620 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects of Metformin on Obesity
NCT01910246 ·Status: WITHDRAWN ·Phase: PHASE4
-
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
NCT06825182 ·Status: RECRUITING ·Phase: PHASE3
-
Modulation of Human Myocardial Metabolism by GLP-1 Dose Response
NCT01607450 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intermittent Fasting in Adults With Type 1 Diabetes
NCT06134986 ·Status: COMPLETED ·Phase: NA
-
The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus
NCT00145379 ·Status: COMPLETED ·Phase: PHASE4
-
Hepatic Metabolic Changes in Response to Glucagon Infusion
NCT03526445 ·Status: COMPLETED ·Phase: NA